Entering text into the input field will update the search result below

Egalet Q2 revenues up 18%

  • Egalet (EGLT) Q2 results: Revenues: $7.4M (+17.5%).
  • SPRIX Nasal Spray: $5.4M; OXAYDO: $1.7M; ARYMO ER: $0.4M.
  • Net Loss: ($12M) (+54.7%); Loss Per Share: ($0.22) (+78.8%).

Recommended For You

Related Stocks

SymbolLast Price% Chg
ZCOR--
Zyla Life Sciences